- Home
- ATYR vs BEAT Comparison
ATYR vs BEAT Comparison
Compare ATYR & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATYR | BEAT |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | 58 | 16 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.9M | 53.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ATYR | BEAT |
|---|---|---|
| Price | $0.53 | $0.88 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $3.67 | ★ $5.63 |
| AVG Volume (30 Days) | ★ 4.1M | 611.2K |
| Earning Date | 05-01-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.40 | $0.54 |
| 52 Week High | $7.29 | $4.00 |
Technical Indicators
Market Signals| Indicator | ATYR | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 41.90 |
| Support Level | $0.40 | $0.81 |
| Resistance Level | $0.86 | $1.28 |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 23.15 | 5.62 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.